Total Payments
$10,628
2024 Payments
$1,571
Companies
54
Transactions
543
Medicare Patients
3,862
Medicare Billing
$245,320
Payment Breakdown by Category
Food & Beverage$10,614 (99.9%)
Education$13.75 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,614 | 541 | 99.9% |
| Education | $13.75 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,503 | 80 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,403 | 49 | $0 (2024) |
| Lilly USA, LLC | $753.30 | 45 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $700.61 | 37 | $0 (2024) |
| ABBVIE INC. | $699.01 | 42 | $0 (2024) |
| GlaxoSmithKline, LLC. | $660.47 | 29 | $0 (2024) |
| PFIZER INC. | $473.00 | 29 | $0 (2024) |
| Amarin Pharma Inc. | $455.09 | 16 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $452.80 | 22 | $0 (2024) |
| Daiichi Sankyo Inc. | $264.83 | 13 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,571 | 84 | ABBVIE INC. ($307.93) |
| 2023 | $1,868 | 91 | Lilly USA, LLC ($233.30) |
| 2022 | $1,461 | 93 | Boehringer Ingelheim Pharmaceuticals, Inc. ($166.97) |
| 2021 | $1,468 | 88 | Novo Nordisk Inc ($185.57) |
| 2020 | $823.17 | 49 | Novo Nordisk Inc ($245.81) |
| 2019 | $1,327 | 70 | AstraZeneca Pharmaceuticals LP ($353.33) |
| 2018 | $1,601 | 53 | AstraZeneca Pharmaceuticals LP ($472.54) |
| 2017 | $509.33 | 15 | Novo Nordisk Inc ($136.11) |
All Payment Transactions
543 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: PAIN | ||||||
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Endocrinology | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Biological | ||||||
| 11/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | PEDIARIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: VACCINES | ||||||
| 10/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Inflammation | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Gastroenterology | ||||||
| 10/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.41 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: PAIN | ||||||
| 10/01/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: Oncology | ||||||
| 09/26/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Inflammation | ||||||
| 09/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/12/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 08/26/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Cardiology | ||||||
| 08/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,480 | 1,851 | $353,704 | $101,900 |
| 2022 | 18 | 742 | 939 | $103,568 | $50,730 |
| 2021 | 21 | 1,167 | 2,169 | $148,336 | $71,734 |
| 2020 | 12 | 473 | 585 | $56,912 | $20,955 |
Total Patients
3,862
Total Services
5,544
Medicare Billing
$245,320
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 238 | 347 | $119,379 | $28,755 | 24.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 214 | 384 | $91,824 | $22,607 | 24.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 156 | 156 | $46,184 | $18,275 | 39.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 88 | 89 | $18,420 | $6,395 | 34.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 17 | 17 | $14,722 | $4,809 | 32.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 27 | $13,323 | $3,382 | 25.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 19 | 19 | $3,489 | $2,855 | 81.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 145 | 145 | $6,156 | $2,480 | 40.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 12 | 12 | $7,637 | $2,313 | 30.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $10,596 | $2,262 | 21.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 89 | 90 | $1,552 | $1,521 | 98.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 37 | 43 | $3,169 | $1,448 | 45.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 73 | 78 | $3,745 | $1,023 | 27.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 85 | 100 | $2,796 | $952.00 | 34.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 44 | 78 | $3,172 | $770.11 | 24.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $3,645 | $593.82 | 16.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 14 | 14 | $1,360 | $484.68 | 35.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 22 | 22 | $409.33 | $401.17 | 98.0% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 14 | 15 | $826.00 | $349.61 | 42.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 13 | 14 | $259.00 | $100.10 | 38.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 15 | 16 | $135.00 | $51.15 | 37.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 16 | 17 | $119.00 | $37.40 | 31.4% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 34 | 39 | $121.50 | $26.89 | 22.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 43 | 56 | $522.16 | $5.02 | 1.0% |
| J0461 | Injection, atropine sulfate, 0.01 mg | Office | 2023 | 35 | 40 | $142.56 | $2.40 | 1.7% |
About Dr. Christopher Dingess, D.O
Dr. Christopher Dingess, D.O is a Family Medicine healthcare provider based in Keller, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/21/2014. The National Provider Identifier (NPI) number assigned to this provider is 1982016192.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Dingess, D.O has received a total of $10,628 in payments from pharmaceutical and medical device companies, with $1,571 received in 2024. These payments were reported across 543 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($10,614).
As a Medicare-enrolled provider, Dingess has provided services to 3,862 Medicare beneficiaries, totaling 5,544 services with total Medicare billing of $245,320. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Keller, TX
- Active Since 05/21/2014
- Last Updated 07/21/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1982016192
Products in Payments
- FARXIGA (Drug) $1,339
- JARDIANCE (Drug) $607.02
- Ozempic (Drug) $548.18
- NURTEC ODT (Drug) $538.33
- Vascepa (Drug) $455.09
- Kerendia (Drug) $452.80
- SHINGRIX (Biological) $342.81
- Saxenda (Drug) $326.54
- EMGALITY (Drug) $313.17
- UBRELVY (Drug) $312.96
- VRAYLAR (Drug) $280.50
- INJECTAFER (Drug) $264.83
- MOUNJARO (Drug) $222.97
- Rybelsus (Drug) $220.22
- XIFAXAN (Drug) $185.19
- QULIPTA (Drug) $174.87
- FREESTYLE LIBRE 2 (Device) $174.32
- TRELEGY ELLIPTA (Drug) $170.92
- Victoza (Drug) $158.94
- RYBELSUS (Drug) $157.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Keller
Dr. Gregory Fuller, M.d, M.D
Family Medicine — Payments: $35,322
Family Medicine $35,322
Dr. William Musgrave, D.o, D.O
Family Medicine — Payments: $19,947
Family Medicine $19,947
Roger Tolar, Md, MD
Family Medicine — Payments: $18,111
Family Medicine $18,111
Dr. Shital Rana, Md, MD
Family Medicine — Payments: $11,770
Family Medicine $11,770
Pamela Martin, Md, MD
Family Medicine — Payments: $6,249
Family Medicine $6,249
Gerald Ray, Do, DO
Family Medicine — Payments: $5,499
Family Medicine $5,499